Assessment of Use of Combined Dextromethorphan and Quinidine in Patients with Dementia or Parkinson Disease After US Food and Drug Administration Approval for Pseudobulbar Affect

Program On Regulation, Therapeutics, And Law (PORTAL)
Division of Pharmacoepidemiology and Pharmacoeconomics
Brigham and Women's Hospital • Harvard Medical School
41 Avenue Louis Pasteur, Suite 0B17, Boston, MA 02115